Progress in stem cell therapy for the diabetic foot

Diabetes Research and Clinical Practice

Volumn 97, Issue 1, 2012, Pages 43-50

  Jiang, Xiao Yan ^a   Lu, De Bin ^a   Chen, Bing ^a  

^a THIRD MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Diabetes complications; Diabetes mellitus; Foot ulcer; Limb ischemia; Stem cell

Indexed keywords

GRANULOCYTE COLONY STIMULATING FACTOR;

ADIPOSE TISSUE STEM CELL; ADULT STEM CELL; ANGIOGENESIS; ANGIOPLASTY; ATHERECTOMY; BYPASS SURGERY; CELL AGING; CELL DIFFERENTIATION; CELL RENEWAL; CLINICAL TRIAL (TOPIC); CORD BLOOD STEM CELL TRANSPLANTATION; DIABETIC ANGIOPATHY; DIABETIC FOOT; DIABETIC NEUROPATHY; DISEASE COURSE; EMBRYONIC STEM CELL; FEASIBILITY STUDY; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; INFECTION; LEG BLOOD FLOW; LEG REVASCULARIZATION; LIMB ISCHEMIA; MESENCHYMAL STEM CELL TRANSPLANTATION; NONHUMAN; PATHOGENESIS; PATIENT SAFETY; PERIPHERAL BLOOD MONONUCLEAR CELL; REVIEW; STEM CELL; STEM CELL EXPANSION; STEM CELL MOBILIZATION; STEM CELL TRANSPLANTATION; STENT; TISSUE INJURY; WOUND HEALING;

AMPUTATION; ANIMALS; CHINA; DIABETIC FOOT; FEASIBILITY STUDIES; FEMALE; HUMANS; ISCHEMIA; LEG; MALE; NEOVASCULARIZATION, PHYSIOLOGIC; RANDOMIZED CONTROLLED TRIALS AS TOPIC; STEM CELL TRANSPLANTATION; TREATMENT OUTCOME; WOUND HEALING;

EID: 84864088006     PISSN: 01688227     EISSN: 18728227     Source Type: Journal    
DOI: 10.1016/j.diabres.2011.12.011     Document Type: Review

References (86)

1. Singh N., Armstrong D.G., Lipsky B.A. Preventing foot ulcers in patients with diabetes. JAMA 2005, 293(2):217-228.
2. Abbott C.A., Garrow A.P., Carrington A.L., Morris J., Van Ross E.R., Boulton A.J. Foot ulcer risk is lower in South-Asian and african-Caribbean compared with European diabetic patients in the U.K.: the North-West diabetes foot care study. Diabetes Care 2005, 28(8):1869-1875.
3. Katz I.A., Harlan A., Miranda-Palma B., Prieto-Sanchez L., Armstrong D.G., Bowker J.H., et al. A randomized trial of two irremovable off-loading devices in the management of plantar neuropathic diabetic foot ulcers. Diabetes Care 2005, 28(3):555-559.
4. Prompers L., Schaper N., Apelqvist J., Edmonds M., Jude E., Mauricio D., et al. Prediction of outcome in individuals with diabetic foot ulcers: focus on the differences between individuals with and without peripheral arterial disease. The EURODIALE Study. Diabetologia 2008, 51(5):747-755.
5. Jonasson J.M., Ye W., Sparen P., Apelqvist J., Nyren O., Brismar K. Risks of nontraumatic lower-extremity amputations in patients with type 1 diabetes: a population-based cohort study in Sweden. Diabetes Care 2008, 31(8):1536-1540.
6. Larsson J., Agardh C.D., Apelqvist J., Stenstrom A. Long-term prognosis after healed amputation in patients with diabetes. Clin Orthop Relat Res 1998, 350:149-158.
7. Consensus development conference on diabetic foot wound care: 7-8 April 1999, Boston, Massachusetts. American Diabetes Association. Diabetes Care 1999, 22(8):1354-1360.
8. Mills J.L. Open bypass and endoluminal therapy: complementary techniques for revascularization in diabetic patients with critical limb ischaemia. Diabetes Metab Res Rev 2008, 24(Suppl. 1):S34-S39.
9. Pomposelli F.B., Kansal N., Hamdan A.D., Belfield A., Sheahan M., Campbell D.R., et al. A decade of experience with dorsalis pedis arterybypass: analysis of outcome in more than 1000 cases. J Vasc Surg 2003, 37(2):307-315.
10. Sigala F., Georgopoulos S., Langer S., Baunach C., Papalambros E., Sigalas K., et al. Outcome of infrainguinal revascularization for critical limb ischemia in diabetics with end stage renal disease. Vasa 2006, 35(1):15-20.
11. Virkkunen J., Heikkinen M., Lepantalo M., Metsanoja R., Salenius J.P. Diabetes as an independent risk factor for early postoperative complications in critical limb ischemia. J Vasc Surg 2004, 40(4):761-767.
12. Chen F.H., Tuan R.S. Mesenchymal stem cells in arthritic diseases. Arthritis Res Ther 2008, 10(5):223.
13. Prochazka V., Gumulec J., Chmelova J., Klement P., Klement G.L., Jonszta T., et al. Autologous bone marrow stem cell transplantation in patients with end-stage chronical critical limb ischemia and diabetic foot. Vnitr Lek 2009, 55(3):173-178.
14. Badiavas E.V., Falanga V. Treatment of chronic wounds with bone marrow-derived cells. Arch Dermatol 2003, 139:510-516.
15. Humpert P.M., Bartsch U., Konrade I., Hammes H.P., Morcos M., Kasper M., et al. Locally applied mononuclear bone marrow cells restore angiogenesis and promote wound healing in a type 2 diabetic patient. Exp Clin Endocrinol Diabetes 2005, 113:538-540.
16. Rogers L.C., Bevilacqua N.J., Armstrong D.G. The use of marrow-derived stem cells to accelerate healing in chronic wounds. Int Wound J 2008, 5:20-25.
17. Ichioka S., Kouraba S., Sekiya N., Ohura N., Nakatsuka T. Bone marrow-impregnated collagen matrix for wound healing: experimental evaluation in a microcirculatory model of angiogenesis, and clinical experience. Br J Plast Surg 2005, 58:1124-1130.
18. Mizuno H., Akaishi S., Koike S., Hyakusoku H., Miyamoto M. Clinical application of collagen matrix impregnated with bone marrow-derived mononuclear cells for ischemic refractory skin ulcers. J Jpn Plast Reconstr Surg 2006, 26:726-732.
19. Ravari H., Hamidi-Almadari D., Salimifar M., Bonakdaran S., Parizadeh M.R., Koliakos G. Treatment of non-healing wounds with autologous bone marrow cells, platelets, fibrin glue and collagen matrix. Cytotherapy 2011, 13(July (6)):705-711. [Epub 2011 Feb 2].
20. Liu Z.J., Velazquez O.C. Hyperoxia, endothelial progenitor cell mobilization, and diabetic wound healing. Antioxid Redox Signal 2008, 10(11):1869-1882.
21. Asahara T., Masuda H., Takahashi T., Kalka C., Pastore C., Silver M., et al. Bone marrow origin of endothelial progenitor cells responsible for postnatal vasculogenesis in physiological and pathological neovascularization. Circ Res 1999, 85(3):221-228.
22. Schatteman G.C., Dunnwald M., Jiao C. Biology of bone marrow-derived endothelial cell precursors. Am J Physiol Heart Circ Physiol 2007, 292(1):H1-H18.
23. Sata M., Saiura A., Kunisato A., Tojo A., Okada S., Tokuhisa T., et al. Hematopoietic stem cells differentiate into vascular cells that participate in the pathogenesis of atherosclerosis. Nat Med 2002, 8(4):403-409.
24. Xu Q., Zhang Z., Davison F., Hu Y. Circulating progenitor cells regenerate endothelium of vein graft atherosclerosis, which is diminished in ApoE-deficient mice. Circ Res 2003, 93(8):e76-e86.
25. Griese D.P., Ehsan A., Melo L.G., Kong D., Zhang L., Mann M.J., et al. Isolation and transplantation of autologous circulating endothelial cells into denuded vessels and prosthetic grafts: implications for cell-based vascular therapy. Circulation 2003, 108(21):2710-2715.
26. Werner N., Junk S., Laufs U., Link A., Walenta K., Bohm M., et al. Intravenous transfusion of endothelial progenitor cells reduces neointima formation after vascular injury. Circ Res 2003, 93(2):e17-e24.
27. Kalka C., Masuda H., Takahashi T., Kalka-Moll W.M., Silver M., Kearney M., et al. Transplantation of ex vivo expanded endothelial progenitor cells for therapeutic neovascularization. Proc Natl Acad Sci U S A 2000, 97(7):3422-3427.
28. Murasawa S., Asahara T. Endothelial progenitor cells for vasculogenesis. Physiology (Bethesda) 2005, 20:36-42.
29. Loomans C.J., de Koning E.J., Staal F.J., Rookmaaker M.B., Verseyden C., de Boer H.C., et al. Endothelial progenitor cell dysfunction: a novel concept in the pathogenesis of vascular complications of type 1 diabetes. Diabetes 2004, 53(1):195-199.
30. Loomans C.J., van Haperen R., Duijs J.M., Verseyden C., de Crom R., Leenen P.J., et al. Differentiation of bone marrow-derived endothelial progenitor cells is shifted into a proinflammatory phenotype by hyperglycemia. Mol Med 2009, 15(5-6):152-159.
31. Li Calzi S., Neu M.B., Shaw L.C., Grant M.B. Endothelial progenitor dysfunction in the pathogenesis of diabetic retinopathy: treatment concept to correct diabetes-associated deficits. EPMA J 2010, 1(1):88-100.
32. Imanishi T., Hano T., Sawamura T., Nishio I. Oxidized low-density lipoprotein induces endothelial progenitor cell senescence, leading to cellular dysfunction. Clin Exp Pharmacol Physiol 2004, 31(7):407-413.
33. Antonio N., Fernandes R., Ribeiro C.F., Providencia L.A. Challenges in vascular repair by endothelial progenitor cells in diabetic patients. Cardiovasc Hematol Disord Drug Targets 2010, 10(3):161-166.
34. Fadini G.P., Miorin M., Facco M., Bonamico S., Baesso I., Grego F., et al. Circulating endothelial progenitor cells are reduced in peripheral vascular complications of type 2 diabetes mellitus. J Am Coll Cardiol 2005, 45(9):1449-1457.
35. Hamano K., Li T.S., Kobayashi T., Tanaka N., Kobayashi S., Matsuzaki M., et al. The induction of angiogenesis by the implantation of autologous bone marrow cells: a novel and simple therapeutic method. Surgery 2001, 130(1):44-54.
36. Ikenaga S., Hamano K., Nishida M., Kobayashi T., Li T.S., Kobayashi S., et al. Autologous bone marrow implantation induced angiogenesis and improved deteriorated exercise capacity in a rat ischemic hindlimb model. J Surg Res 2001, 96(2):277-283.
37. Shintani S., Murohara T., Ikeda H., Ueno T., Sasaki K., Duan J., et al. Augmentation of postnatal neovascularization with autologous bone marrow transplantation. Circulation 2001, 103(6):897-903.
38. Dimmeler S., Zeiher A.M., Schneider M.D. Unchain my heart: the scientific foundations of cardiac repair. J Clin Invest 2005, 115(3):572-583.
39. Bartsch T., Brehm M., Zeus T., Strauer B.E. Autologous mononuclear stem cell transplantation in patients with peripheral occlusive arterial disease. J Cardiovasc Nurs 2006, 21(6):430-432.
40. Strauer B.E., Brehm M., Zeus T., Kostering M., Hernandez A., Sorg R.V., et al. Repair of infarcted myocardium by autologous intracoronary mononuclear bone marrow cell transplantation in humans. Circulation 2002, 106(15):1913-1918.
41. Stamm C., Westphal B., Kleine H.D., Petzsch M., Kittner C., Klinge H., et al. Autologous bone-marrow stem-cell transplantation for myocardial regeneration. Lancet 2003, 361(9351):45-46.
42. Hirata K., Li T.S., Nishida M., Ito H., Matsuzaki M., Kasaoka S., et al. Autologous bone marrow cell implantation as therapeutic angiogenesis for ischemic hindlimb in diabetic rat model. Am J Physiol Heart Circ Physiol 2003, 284(1):H66-H70.
43. Tateishi-Yuyama E., Matsubara H., Murohara T., Ikeda U., Shintani S., Masaki H., et al. Therapeutic angiogenesis for patients with limb ischaemia by autologous transplantation of bone-marrow cells: a pilot study and a randomised controlled trial. Lancet 2002, 360(9331):427-435.
44. Gabr H., Hedayet A., Imam U., Nasser M. Limb salvage using intramuscular injection of unfractionated autologous bone marrow mononuclear cells in critical limb ischemia: a prospective pilot clinical trial. Exp Clin Transplant 2011, 9(3):197-202.
45. Bartsch T., Brehm M., Falke T., Kogler G., Wernet P., Strauer B.E. Rapid healing of a therapy-refractory diabetic foot after transplantation of autologous bone marrow stem cells. Med Klin (Munich) 2005, 100(10):676-680.
46. Kawamura A., Horie T., Tsuda I., Ikeda A., Egawa H., Imamura E., et al. Prevention of limb amputation in patients with limbs ulcers by autologous peripheral blood mononuclear cell implantation. Ther Apher Dial 2005, 9(1):59-63.
47. Huang P., Li S., Han M., Xiao Z., Yang R., Han Z.C. Autologous transplantation of granulocyte colony-stimulating factor-mobilized peripheral blood mononuclear cells improves critical limb ischemia in diabetes. Diabetes Care 2005, 28(9):2155-2160.
48. da Silva Meirelles L., Chagastelles P.C., Nardi N.B. Mesenchymal stem cells reside in virtually all post-natal organs and tissues. J Cell Sci 2006, 119(Pt 11):2204-2213.
49. Kassis I., Zangi L., Rivkin R., Levdansky L., Samuel S., Marx G., et al. Isolation of mesenchymal stem cells from G-CSF-mobilized human peripheral blood using fibrin microbeads. Bone Marrow Transplant 2006, 37(10):967-976.
50. Zou Z., Zhang Y., Hao L., Wang F., Liu D., Su Y., et al. More insight into mesenchymal stem cells and their effects inside the body. Expert Opin Biol Ther 2010, 10(2):215-230.
51. Al-Khaldi A., Eliopoulos N., Martineau D., Lejeune L., Lachapelle K., Galipeau J. Postnatal bone marrow stromal cells elicit a potent VEGF-dependent neoangiogenic response in vivo. Gene Ther 2003, 10(8):621-629.
52. Gruber R., Kandler B., Holzmann P., Vogele-Kadletz M., Losert U., Fischer M.B., et al. Bone marrow stromal cells can provide a local environment that favors migration and formation of tubular structures of endothelial cells. Tissue Eng 2005, 11(5-6):896-903.
53. Kinnaird T., Stabile E., Burnett M.S., Lee C.W., Barr S., Fuchs S., et al. Marrow-derived stromal cells express genes encoding a broad spectrum of arteriogenic cytokines and promote in vitro and in vivo arteriogenesis through paracrine mechanisms. Circ Res 2004, 94(5):678-685.
54. Reyes M., Dudek A., Jahagirdar B., Koodie L., Marker P.H., Verfaillie C.M. Origin of endothelial progenitors in human postnatal bone marrow. J Clin Invest 2002, 109(3):337-346.
55. Al-Khaldi A., Al-Sabti H., Galipeau J., Lachapelle K. Therapeutic angiogenesis using autologous bone marrow stromal cells: improved blood flow in a chronic limb ischemia model. Ann Thorac Surg 2003, 75(1):204-209.
56. Kwon D.S., Gao X., Liu Y.B., Dulchavsky D.S., Danyluk A.L., Bansal M., et al. Treatment with bone marrow-derived stromal cells accelerates wound healing in diabetic rats. Int Wound J 2008, 5(3):453-463.
57. Wu Y., Chen L., Scott P.G., Tredget E.E. Mesenchymal stem cells enhance wound healing through differentiation and angiogenesis. Stem Cells 2007, 25(10):2648-2659.
58. Falanga V., Iwamoto S., Chartier M., Yufit T., Butmarc J., Kouttab N., et al. Autologous bone marrow-derived cultured mesenchymal stem cells delivered in a fibrin spray accelerate healing in murine and human cutaneous wounds. Tissue Eng 2007, 13(6):1299-1312.
59. Inoue H., Murakami T., Ajiki T., Hara M., Hoshino Y., Kobayashi E. Bioimaging assessment and effect of skin wound healing using bone-marrow-derived mesenchymal stromal cells with the artificial dermis in diabetic rats. J Biomed Opt 2008, 13(6):064036.
60. Vojtassak J., Danisovic L., Kubes M., Bakos D., Jarabek L., Ulicna M., et al. Autologous biograft and mesenchymal stem cells in treatment of the diabetic foot. Neuro Endocrinol Lett 2006, 27(Suppl. 2):134-137.
61. Lu D., Chen B., Liang Z., Deng W., Jiang Y., Li S., et al. Comparison of bone marrow mesenchymal stem cells with bone marrow-derived mononuclear cells for treatment of diabetic critical limb ischemia and foot ulcer: a double-blind, randomized, controlled trial. Diabetes Res Clin Pract 2011.
62. Erickson G.R., Gimble J.M., Franklin D.M., Rice H.E., Awad H., Guilak F. Chondrogenic potential of adipose tissue-derived stromal cells in vitro and in vivo. Biochem Biophys Res Commun 2002, 290(2):763-769.
63. Fraser J.K., Wulur I., Alfonso Z., Hedrick M.H. Fat tissue: an underappreciated source of stem cells for biotechnology. Trends Biotechnol 2006, 24(4):150-154.
64. Halvorsen Y.D., Franklin D., Bond A.L., Hitt D.C., Auchter C., Boskey A.L., et al. Extracellular matrix mineralization and osteoblast gene expression by human adipose tissue-derived stromal cells. Tissue Eng 2001, 7(6):729-741.
65. Rodriguez L.V., Alfonso Z., Zhang R., Leung J., Wu B., Ignarro L.J. Clonogenic multipotent stem cells in human adipose tissue differentiate into functional smooth muscle cells. Proc Natl Acad Sci U S A 2006, 103(32):12167-12172.
66. Kang S.K., Putnam L.A., Ylostalo J., Popescu I.R., Dufour J., Belousov A., et al. Neurogenesis of Rhesus adipose stromal cells. J Cell Sci 2004, 117(Pt 18):4289-4299.
67. Kim Y., Kim H., Cho H., Bae Y., Suh K., Jung J. Direct comparison of human mesenchymal stem cells derived from adipose tissues and bone marrow in mediating neovascularization in response to vascular ischemia. Cell Physiol Biochem 2007, 20(6):867-876.
68. Blanton M.W., Hadad I., Johnstone B.H., Mund J.A., Rogers P.I., Eppley B.L., et al. Adipose stromal cells and platelet-rich plasma therapies synergistically increase revascularization during wound healing. Plast Reconstr Surg 2009, 123(Suppl. 2):56S-64S.
69. Lu F., Mizuno H., Uysal C.A., Cai X., Ogawa R., Hyakusoku H. Improved viability of random pattern skin flaps through the use of adipose-derived stem cells. Plast Reconstr Surg 2008, 121(1):50-58.
70. Nambu M., Kishimoto S., Nakamura S., Mizuno H., Yanagibayashi S., Yamamoto N., et al. Accelerated wound healing in healing-impaired db/db mice by autologous adipose tissue-derived stromal cells combined with atelocollagen matrix. Ann Plast Surg 2009, 62(3):317-321.
71. Amos P.J., Kapur S.K., Stapor P.C., Shang H., Bekiranov S., Khurgel M., et al. Human adipose-derived stromal cells accelerate diabetic wound healing: impact of cell formulation and delivery. Tissue Eng Part A 2010, 16(5):1595-1606.
72. Maharlooei M.K., Bagheri M., Solhjou Z., Jahromi B.M., Akrami M., Rohani L., et al. Adipose tissue derived mesenchymal stem cell (AD-MSC) promotes skin wound healing in diabetic rats. Diabetes Res Clin Pract 2011.
73. Kim W.S., Park B.S., Sung J.H. The wound-healing and antioxidant effects of adipose-derived stem cells. Expert Opin Biol Ther 2009, 9(7):879-887.
74. Kim W.S., Park B.S., Sung J.H., Yang J.M., Park S.B., Kwak S.J., et al. Wound healing effect of adipose-derived stem cells: a critical role of secretory factors on human dermal fibroblasts. J Dermatol Sci 2007, 48(1):15-24.
75. Hong S.J., Traktuev D.O., March K.L. Therapeutic potential of adipose-derived stem cells in vascular growth and tissue repair. Curr Opin Organ Transplant 2010, 15(1):86-91.
76. Luo G., Cheng W., He W., Wang X., Tan J., Fitzgerald M., et al. Promotion of cutaneous wound healing by local application of mesenchymal stem cells derived from human umbilical cord blood. Wound Repair Regen 2010, 18(5):506-513.
77. Tark K.C., Hong J.W., Kim Y.S., Hahn S.B., Lee W.J., Lew D.H. Effects of human cord blood mesenchymal stem cells on cutaneous wound healing in leprdb mice. Ann Plast Surg 2010, 65(6):565-572.
78. Valbonesi M., Giannini G., Migliori F., Dalla Costa R., Dejana A.M. Cord blood (CB) stem cells for wound repair Preliminary report of 2 cases. Transfus Apher Sci 2004, 30(2):153-156.
79. Marr R.A., Thomas R.M., Peterson D.A. Insights into neurogenesis and aging: potential therapy for degenerative disease?. Future Neurol 2010, 5(4):527-541.
80. Jin P., Zhang X., Wu Y., Li L., Yin Q., Zheng L., et al. Streptozotocin-induced diabetic rat-derived bone marrow mesenchymal stem cells have impaired abilities in proliferation, paracrine, antiapoptosis, and myogenic differentiation. Transplant Proc 2010, 42(7):2745-2752.
81. Cramer C., Freisinger E., Jones R.K., Slakey D.P., Dupin C.L., Newsome E.R., et al. Persistent high glucose concentrations alter the regenerative potential of mesenchymal stem cells. Stem Cells Dev 2010, 19(12):1875-1884.
82. Wagner W., Ho A.D., Zenke M. Different facets of aging in human mesenchymal stem cells. Tissue Eng Part B Rev 2010, 16(4):445-453.
83. Meng J., Yao X., Kang S., Yang Y., Zhou C. Treatment of ischemic limbs by transplantation of G-CSF stimulated bone marrow cells in diabetic rabbits. Clin Invest Med 2010, 33(3):E174-E180.
84. Hung S.C., Chen N.J., Hsieh S.L., Li H., Ma H.L., Lo W.H. Isolation and characterization of size-sieved stem cells from human bone marrow. Stem Cells 2002, 20(3):249-258.
85. Caterson E.J., Nesti L.J., Danielson K.G., Tuan R.S. Human marrow-derived mesenchymal progenitor cells: isolation, culture expansion, and analysis of differentiation. Mol Biotechnol 2002, 20(3):245-256.
86. Badiavas E.V., Ford D., Liu P., Kouttab N., Morgan J., Richards A., et al. Long-term bone marrow culture and its clinical potential in chronic wound healing. Wound Repair Regen 2007, 15:856-865.